,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Product use in unapproved indication,6,16849276
1,22.0,Hypertension,6,16849276
2,22.0,Off label use,6,16849276
0,22.0,Polyneuropathy,3,16849308
1,22.0,Constipation,6,16849308
2,22.0,Alopecia,3,16849308
3,22.0,Neutropenia,3,16849308
4,22.0,Hypertension,3,16849308
5,22.0,Fatigue,3,16849308
6,22.0,Leukopenia,3,16849308
7,22.0,Hypersensitivity,6,16849308
0,22.0,Malaise,5,16849330
1,22.0,Death,5,16849330
2,22.0,Movement disorder,5,16849330
3,22.0,Somnolence,5,16849330
4,22.0,Peripheral swelling,5,16849330
5,22.0,Eczema,5,16849330
6,22.0,Oedema,5,16849330
7,22.0,Lymphatic disorder,5,16849330
0,22.1,Diarrhoea,1,16849382
1,22.1,Rash,1,16849382
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16849382
3,22.1,Condition aggravated,2,16849382
4,22.1,Asthenia,1,16849382
5,22.1,Oesophagitis,1,16849382
6,22.1,Lower respiratory tract infection,1,16849382
7,22.1,Klebsiella infection,1,16849382
8,22.1,Pseudomonas test positive,1,16849382
9,22.1,Aeromonas infection,1,16849382
10,22.1,Escherichia infection,1,16849382
11,22.1,Drug interaction,6,16849382
12,22.1,Stomatitis,1,16849382
13,22.1,Pharyngeal inflammation,1,16849382
14,22.1,Candida infection,1,16849382
15,22.1,Pancytopenia,1,16849382
0,22.1,Supraventricular tachycardia,6,16849385
0,22.1,Liver injury,1,16849387
0,22.1,Chest discomfort,6,16849400
1,22.1,Hepatic steatosis,6,16849400
2,22.1,Nasopharyngitis,6,16849400
3,22.1,Arthralgia,3,16849400
4,22.1,Oropharyngeal pain,6,16849400
5,22.1,Prostate cancer,6,16849400
6,22.1,Rheumatoid arthritis,2,16849400
7,22.1,Liver disorder,6,16849400
8,22.1,Anxiety,6,16849400
9,22.1,Dry throat,6,16849400
10,22.1,Cough,6,16849400
0,22.0,Thrombocytopenia,6,16849410
1,22.0,Haemoglobinuria,6,16849410
2,22.0,Haemolytic anaemia,6,16849410
3,22.0,Acute kidney injury,6,16849410
0,22.1,Pneumonia,1,16849427
1,22.1,Febrile neutropenia,2,16849427
0,22.1,Viral infection,,16849457
0,22.0,Oculomucocutaneous syndrome,2,16849483
0,22.0,Oesophagitis,6,16849525
1,22.0,Chest pain,6,16849525
0,22.0,Death,5,16849554
0,22.0,Small cell lung cancer,1,16849568
1,22.0,Malignant transformation,1,16849568
2,22.0,Malignant neoplasm progression,2,16849568
0,22.1,Malignant neoplasm progression,6,16849569
1,22.1,Renal impairment,1,16849569
0,22.0,Malignant neoplasm progression,6,16849570
0,22.1,Abscess limb,1,16849571
1,22.1,Haematoma,6,16849571
0,22.0,Pericardial effusion,6,16849593
0,22.1,Sensory disturbance,,16849616
1,22.1,Hypoaesthesia,,16849616
2,22.1,Oral discomfort,,16849616
0,22.1,Feeding disorder,1,16849622
1,22.1,Vomiting,1,16849622
2,22.1,General physical health deterioration,2,16849622
3,22.1,Hypotension,1,16849622
0,22.1,Hospice care,,16849625
0,22.1,Hepatic neoplasm,2,16849655
0,22.0,Constipation,6,16849666
1,22.0,Carbohydrate antigen 125 increased,3,16849666
2,22.0,Neoplasm progression,6,16849666
3,22.0,Drug ineffective,6,16849666
0,22.1,Adverse drug reaction,3,16849689
1,22.1,Palpitations,3,16849689
2,22.1,Nasopharyngitis,2,16849689
3,22.1,Fluid intake reduced,1,16849689
4,22.1,Haemoglobin decreased,1,16849689
5,22.1,Blood pressure increased,1,16849689
6,22.1,Loss of personal independence in daily activities,2,16849689
7,22.1,Abdominal discomfort,3,16849689
8,22.1,Muscle spasms,2,16849689
9,22.1,Taste disorder,3,16849689
10,22.1,Computerised tomogram abnormal,6,16849689
11,22.1,Post-traumatic pain,2,16849689
12,22.1,Pain,1,16849689
13,22.1,Fatigue,3,16849689
14,22.1,Anxiety,3,16849689
15,22.1,Chest pain,3,16849689
16,22.1,Dizziness,1,16849689
17,22.1,Malaise,3,16849689
18,22.1,Heart rate increased,1,16849689
19,22.1,Cough,2,16849689
20,22.1,Nausea,1,16849689
21,22.1,Muscle strain,1,16849689
22,22.1,Skin lesion,1,16849689
23,22.1,Eastern Cooperative Oncology Group performance status worsened,6,16849689
24,22.1,Injury,6,16849689
25,22.1,Hip deformity,6,16849689
26,22.1,Hypophagia,1,16849689
0,22.1,Bone pain,6,16849691
1,22.1,Dyspnoea exertional,6,16849691
2,22.1,Nausea,1,16849691
3,22.1,Headache,1,16849691
4,22.1,Muscular weakness,3,16849691
5,22.1,Nasal congestion,6,16849691
6,22.1,Epistaxis,1,16849691
7,22.1,Fatigue,3,16849691
8,22.1,Haemoglobin decreased,6,16849691
9,22.1,Inappropriate schedule of product administration,6,16849691
10,22.1,Decreased appetite,1,16849691
11,22.1,Asthenia,3,16849691
12,22.1,Thrombocytopenia,1,16849691
13,22.1,Rhinorrhoea,6,16849691
14,22.1,Dizziness,1,16849691
15,22.1,Neoplasm progression,6,16849691
16,22.1,Blood pressure increased,2,16849691
0,22.1,Neuropathy peripheral,3,16849696
1,22.1,Alopecia,3,16849696
2,22.1,Hypoaesthesia,6,16849696
3,22.1,Weight decreased,1,16849696
4,22.1,Depression,3,16849696
5,22.1,Anxiety,3,16849696
6,22.1,Nausea,1,16849696
7,22.1,Computerised tomogram abnormal,1,16849696
8,22.1,Hypertension,1,16849696
9,22.1,Constipation,3,16849696
10,22.1,Emotional distress,3,16849696
11,22.1,Psychomotor hyperactivity,3,16849696
12,22.1,Androgenetic alopecia,3,16849696
13,22.1,Paraesthesia,6,16849696
14,22.1,Pain,6,16849696
15,22.1,Faeces hard,6,16849696
16,22.1,Hordeolum,3,16849696
17,22.1,Product dose omission,6,16849696
18,22.1,Blood sodium decreased,6,16849696
19,22.1,Initial insomnia,3,16849696
20,22.1,Hot flush,2,16849696
21,22.1,Insomnia,2,16849696
22,22.1,Carbohydrate antigen 125 increased,2,16849696
23,22.1,Intentional underdose,3,16849696
24,22.1,Cataract,6,16849696
25,22.1,Basal cell carcinoma,6,16849696
26,22.1,Nervousness,3,16849696
27,22.1,Decreased appetite,1,16849696
28,22.1,Pruritus,3,16849696
29,22.1,Discomfort,6,16849696
30,22.1,Dehydration,1,16849696
31,22.1,Basosquamous carcinoma,6,16849696
32,22.1,Weight increased,6,16849696
33,22.1,Food craving,6,16849696
34,22.1,Fatigue,1,16849696
0,22.1,Fatigue,3,16849698
1,22.1,Insomnia,6,16849698
2,22.1,Sleep disorder,3,16849698
3,22.1,Platelet count decreased,1,16849698
4,22.1,Cataract operation,1,16849698
5,22.1,Platelet count decreased,6,16849698
6,22.1,Decreased appetite,3,16849698
0,22.1,Insomnia,2,16849703
1,22.1,Platelet count decreased,1,16849703
2,22.1,Transfusion,6,16849703
3,22.1,Haemoglobin increased,6,16849703
4,22.1,Tenderness,6,16849703
5,22.1,Headache,6,16849703
6,22.1,Haemoglobin decreased,2,16849703
0,22.1,Disease progression,,16849705
0,22.0,Mechanical ileus,1,16849723
1,22.0,Weight decreased,1,16849723
0,22.0,Aortic dissection rupture,6,16849743
1,22.0,Nasopharyngitis,6,16849743
2,22.0,Cough,6,16849743
0,22.1,Pneumonia,2,16849768
0,22.1,Disease progression,,16849821
0,22.0,Bone marrow failure,6,16849822
0,22.0,Fall,6,16849826
1,22.0,Product dose omission,6,16849826
0,22.1,Pruritus,,16849840
1,22.1,Throat irritation,,16849840
2,22.1,Infusion related reaction,,16849840
3,22.1,Abdominal pain,,16849840
0,22.1,Disease progression,,16849848
0,22.0,Liver injury,6,16849918
0,22.1,Lichen planus,2,16849928
1,22.1,Stomatitis,1,16849928
0,22.0,Breast cancer stage IV,6,16849938
1,22.0,Malignant neoplasm progression,6,16849938
2,22.0,Metastases to bone,3,16849938
0,22.1,Colitis ischaemic,1,16849996
0,22.0,Pharyngeal swelling,6,16850000
1,22.0,Hypersensitivity,6,16850000
0,22.0,Death,5,16850024
0,22.1,Lymphadenopathy,6,16850091
1,22.1,Skin reaction,6,16850091
2,22.1,Metastases to liver,6,16850091
3,22.1,Cholestasis,6,16850091
4,22.1,Intestinal metastasis,6,16850091
5,22.1,Hydronephrosis,6,16850091
6,22.1,Pleural effusion,6,16850091
0,22.1,Enteritis,,16850117
1,22.1,Clostridium difficile infection,,16850117
2,22.1,Bacterial infection,,16850117
0,22.1,Diverticulitis,6,16850158
1,22.1,Off label use,6,16850158
2,22.1,Malaise,6,16850158
0,22.1,Hepatocellular injury,1,16850184
0,22.1,Product availability issue,6,16850204
1,22.1,Product dose omission,6,16850204
2,22.1,Malignant neoplasm progression,3,16850204
3,22.1,Underdose,6,16850204
0,22.0,Cellulitis,1,16850220
0,22.1,Biopsy,,16850243
1,22.1,Therapy cessation,,16850243
0,22.0,Drug resistance,6,16850290
1,22.0,Acquired gene mutation,6,16850290
2,22.0,Malignant neoplasm progression,6,16850290
0,22.1,Fatigue,2,16850291
1,22.1,Somnolence,2,16850291
2,22.1,General physical health deterioration,6,16850291
3,22.1,Death,5,16850291
4,22.1,Lethargy,2,16850291
0,22.0,Vascular pseudoaneurysm,1,16850296
0,22.0,Anaemia,6,16850302
0,22.0,Weight increased,6,16850310
1,22.0,Fall,6,16850310
2,22.0,Head injury,6,16850310
0,22.1,Neck pain,1,16850375
0,22.1,Neuropathy peripheral,6,16850384
1,22.1,Ovarian cyst,6,16850384
2,22.1,Cardiomegaly,1,16850384
3,22.1,Ejection fraction decreased,1,16850384
0,22.0,Cerebral infarction,3,16850396
1,22.0,Cachexia,5,16850396
0,22.0,Sleep apnoea syndrome,1,16850426
1,22.0,Diverticulitis,1,16850426
2,22.0,Metastases to bone,1,16850426
3,22.0,Tinnitus,1,16850426
4,22.0,Prostatic specific antigen increased,1,16850426
0,22.0,Urinary retention,6,16850459
0,22.1,Pneumonitis,2,16850460
0,22.0,Osteonecrosis of jaw,3,16850461
0,22.0,Dyspnoea,1,16850465
0,22.0,Vascular pseudoaneurysm,1,16850481
1,22.0,Oedema peripheral,1,16850481
0,22.1,Electrocardiogram QT prolonged,3,16850913
1,22.1,Liver function test increased,3,16850913
2,22.1,Gamma-glutamyltransferase increased,6,16850913
0,22.0,Atrial fibrillation,6,16850926
1,22.0,Hypotension,6,16850926
2,22.0,Dry mouth,6,16850926
0,22.0,Sepsis,6,16850935
1,22.0,Subileus,6,16850935
2,22.0,Metastases to peritoneum,6,16850935
3,22.0,Ascites,6,16850935
4,22.0,Cholecystitis acute,6,16850935
0,22.0,Haemoglobin decreased,1,16850960
1,22.0,Lung disorder,2,16850960
0,22.0,Weight decreased,6,16850980
1,22.0,Dehydration,6,16850980
0,22.0,Thrombosis,4,16850995
1,22.0,Metastases to central nervous system,3,16850995
0,22.0,Pain,6,16851106
1,22.0,Nasal disorder,6,16851106
2,22.0,Alopecia,6,16851106
3,22.0,Nerve injury,6,16851106
4,22.0,Full blood count decreased,6,16851106
0,22.0,Abdominal pain,6,16851108
1,22.0,Diarrhoea,2,16851108
2,22.0,Abdominal discomfort,6,16851108
3,22.0,Constipation,6,16851108
4,22.0,Off label use,6,16851108
0,22.1,Diarrhoea,6,16851123
1,22.1,Tumour marker increased,6,16851123
2,22.1,Bone pain,3,16851123
3,22.1,Arthralgia,3,16851123
4,22.1,Neutropenia,6,16851123
5,22.1,Platelet count decreased,1,16851123
6,22.1,Haemoglobin decreased,1,16851123
7,22.1,Leukopenia,6,16851123
0,22.0,Neoplasm progression,6,16851125
0,22.1,Feeling hot,6,16851135
1,22.1,Asthenia,6,16851135
2,22.1,Product use in unapproved indication,6,16851135
3,22.1,Fatigue,6,16851135
4,22.1,Off label use,6,16851135
0,22.0,Product use in unapproved indication,6,16851139
1,22.0,Erythema,2,16851139
2,22.0,Off label use,6,16851139
0,22.0,Hiccups,3,16851148
1,22.0,Hypoaesthesia,3,16851148
2,22.0,Sleep disorder,3,16851148
3,22.0,Tremor,3,16851148
0,22.1,Thrombocytopenia,6,16851151
1,22.1,Neutropenia,6,16851151
2,22.1,Bone marrow failure,6,16851151
3,22.1,Disease progression,6,16851151
4,22.1,Fatigue,6,16851151
0,22.1,Abscess drainage,,16851154
1,22.1,Metastases to lung,,16851154
2,22.1,Metastases to lymph nodes,,16851154
0,22.0,Myocarditis,3,16851168
1,22.0,Hepatitis,3,16851168
2,22.0,Dependence on respirator,3,16851168
3,22.0,Myelitis,3,16851168
0,22.0,Diarrhoea,6,16851171
1,22.0,Crying,6,16851171
0,22.1,Fatigue,6,16851175
0,22.1,Neoplasm progression,3,16851188
0,22.1,Contusion,6,16851189
1,22.1,Muscular weakness,6,16851189
2,22.1,Fatigue,6,16851189
3,22.1,Urinary tract infection,6,16851189
4,22.1,Malaise,2,16851189
5,22.1,Alopecia,6,16851189
6,22.1,White blood cell count decreased,6,16851189
7,22.1,Tooth infection,6,16851189
0,22.0,Neoplasm progression,6,16851192
0,22.1,Neutropenia,6,16851194
0,22.1,White blood cell count decreased,6,16851196
0,22.0,Tremor,6,16851212
0,22.0,White blood cell count decreased,2,16851221
1,22.0,Red blood cell count decreased,2,16851221
2,22.0,Neutrophil count decreased,2,16851221
0,22.0,Back pain,6,16851234
1,22.0,Joint swelling,6,16851234
2,22.0,Pruritus,6,16851234
3,22.0,Rash papular,6,16851234
0,22.1,Asthenia,3,16851236
0,22.0,Nausea,6,16851238
0,22.0,Constipation,2,16851311
1,22.0,Abdominal pain,2,16851311
2,22.0,Subileus,2,16851311
0,22.0,Weight decreased,6,16851319
1,22.0,Pericardial effusion,6,16851319
0,22.0,Hepatitis C,6,16851339
1,22.0,Hepatic enzyme increased,6,16851339
2,22.0,Neoplasm progression,6,16851339
3,22.0,Fibrosis,6,16851339
0,22.1,Alopecia,3,16851342
1,22.1,Fatigue,3,16851342
2,22.1,Lacrimation increased,3,16851342
3,22.1,White blood cell count decreased,3,16851342
0,22.0,Hyperhidrosis,3,16851343
0,22.0,Trigger finger,3,16851351
1,22.0,Neuropathy peripheral,3,16851351
0,22.0,Erythema,2,16851352
1,22.0,Skin exfoliation,2,16851352
2,22.0,Pruritus,2,16851352
0,22.1,Immune-mediated nephritis,1,16851353
0,22.1,Interstitial lung disease,2,16851357
1,22.1,Malignant neoplasm progression,5,16851357
0,22.1,Malaise,6,16851388
0,22.0,Rash,2,16851407
1,22.0,Pruritus generalised,6,16851407
0,22.1,Hair disorder,3,16851415
1,22.1,Hair colour changes,3,16851415
2,22.1,Madarosis,3,16851415
3,22.1,Depression,6,16851415
4,22.1,Hair texture abnormal,3,16851415
5,22.1,Alopecia,3,16851415
0,22.0,Platelet count decreased,5,16851424
0,22.0,Malaise,6,16851446
0,22.0,Tongue ulceration,6,16851453
1,22.0,Dry mouth,6,16851453
2,22.0,Oral pain,6,16851453
0,22.0,Neoplasm progression,6,16851474
0,22.0,Sepsis,6,16851531
1,22.0,Pulmonary fibrosis,5,16851531
2,22.0,Endocarditis,6,16851531
3,22.0,Acute myocardial infarction,6,16851531
0,22.0,Death,5,16851533
0,22.1,Disease progression,6,16851598
1,22.1,General physical health deterioration,6,16851598
2,22.1,Metastases to gastrointestinal tract,5,16851598
0,22.0,Colitis,2,16851602
1,22.0,Abnormal faeces,2,16851602
2,22.0,Abnormal faeces,2,16851602
0,22.0,Death,5,16851605
0,22.0,Death,5,16851628
0,22.0,Acute myocardial infarction,1,16851632
0,22.0,Death,5,16851633
1,22.0,Prostate cancer,5,16851633
0,22.0,Death,5,16851640
0,22.0,Death,5,16851669
0,22.0,Bone marrow failure,6,16851716
1,22.0,Urinary tract infection,6,16851716
2,22.0,Tachycardia,6,16851716
3,22.0,Thrombocytopenia,6,16851716
4,22.0,Neoplasm progression,6,16851716
5,22.0,Leukopenia,6,16851716
6,22.0,Pulmonary embolism,6,16851716
7,22.0,Respiratory distress,6,16851716
8,22.0,Fatigue,6,16851716
9,22.0,Hypokalaemia,6,16851716
10,22.0,Disorientation,6,16851716
11,22.0,Diarrhoea,6,16851716
12,22.0,Anaemia,6,16851716
13,22.0,Deep vein thrombosis,6,16851716
14,22.0,Pleural effusion,6,16851716
15,22.0,Muscular weakness,6,16851716
0,22.1,Neuropathy peripheral,6,16851735
1,22.1,Platelet count decreased,6,16851735
2,22.1,Epistaxis,6,16851735
3,22.1,Mastitis,6,16851735
4,22.1,Oral pain,6,16851735
5,22.1,Weight increased,6,16851735
6,22.1,Neutrophil count decreased,6,16851735
7,22.1,Appetite disorder,6,16851735
8,22.1,White blood cell count decreased,6,16851735
9,22.1,Hot flush,6,16851735
10,22.1,Night sweats,6,16851735
11,22.1,Confusional state,6,16851735
12,22.1,Taste disorder,6,16851735
13,22.1,Constipation,6,16851735
14,22.1,Pruritus,6,16851735
0,22.0,Pulmonary embolism,6,16851736
0,22.0,Pulmonary sepsis,1,16851737
1,22.0,Hypernatraemia,1,16851737
2,22.0,Hypokalaemia,3,16851737
3,22.0,Diarrhoea,1,16851737
4,22.0,Dysphagia,1,16851737
5,22.0,Anaemia,1,16851737
6,22.0,Acute kidney injury,1,16851737
7,22.0,Thrombocytopenia,3,16851737
0,22.0,Malignant neoplasm progression,6,16851802
1,22.0,Hypersensitivity,5,16851802
0,22.0,Arthralgia,6,16851817
0,22.0,Product availability issue,3,16851834
1,22.0,Bladder cancer recurrent,3,16851834
0,22.0,Pneumonitis,6,16851843
0,22.0,Death,5,16851866
0,22.0,Decreased appetite,6,16851867
1,22.0,Nausea,6,16851867
2,22.0,Weight decreased,6,16851867
3,22.0,Off label use,6,16851867
4,22.0,Death,5,16851867
5,22.0,Pneumonia,1,16851867
6,22.0,Asthenia,6,16851867
0,22.1,Death,5,16851868
1,22.1,Nausea,6,16851868
2,22.1,Fall,6,16851868
0,22.0,False positive investigation result,6,16851921
1,22.0,Macroenzyme creatine kinase,6,16851921
0,22.0,Coma,6,16852010
1,22.0,Death,5,16852010
0,22.0,Malaise,1,16852028
1,22.0,Metastases to lung,6,16852028
2,22.0,Decreased appetite,1,16852028
3,22.0,Muscular weakness,1,16852028
4,22.0,Weight decreased,1,16852028
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16852028
0,22.0,Respiratory failure,5,16852048
1,22.0,Malignant neoplasm progression,6,16852048
2,22.0,Metastases to central nervous system,5,16852048
0,22.1,Malignant neoplasm progression,6,16852049
1,22.1,Nausea,1,16852049
0,22.0,Ascites,6,16852064
1,22.0,Infection,6,16852064
2,22.0,Disease progression,5,16852064
3,22.0,Hypocalcaemia,6,16852064
4,22.0,Death,5,16852064
0,22.0,Malignant neoplasm progression,6,16852097
1,22.0,Pruritus,6,16852097
2,22.0,Fatigue,6,16852097
3,22.0,Frequent bowel movements,6,16852097
4,22.0,Faeces soft,6,16852097
5,22.0,Total lung capacity abnormal,6,16852097
6,22.0,Dysphonia,6,16852097
0,22.0,Metastases to central nervous system,2,16852098
1,22.0,Metastases to lung,2,16852098
2,22.0,Breast cancer metastatic,2,16852098
3,22.0,Metastases to bone,2,16852098
4,22.0,Malignant neoplasm progression,2,16852098
5,22.0,Metastases to liver,2,16852098
0,22.1,Coma,1,16852127
1,22.1,Seizure,1,16852127
2,22.1,Hypersensitivity,1,16852127
0,22.1,Madarosis,3,16852140
1,22.1,Hair disorder,3,16852140
2,22.1,Depression,6,16852140
3,22.1,Hair colour changes,3,16852140
4,22.1,Alopecia,3,16852140
5,22.1,Hair texture abnormal,3,16852140
0,22.1,Alopecia,3,16852147
1,22.1,Hair disorder,3,16852147
2,22.1,Hair colour changes,3,16852147
3,22.1,Hair texture abnormal,3,16852147
0,22.1,Underdose,6,16852154
1,22.1,Hypersomnia,2,16852154
2,22.1,Asthenia,2,16852154
0,22.0,Urine odour abnormal,6,16852156
1,22.0,Oedema,6,16852156
2,22.0,Nausea,6,16852156
3,22.0,Chest pain,6,16852156
0,22.1,Dehydration,6,16852164
1,22.1,Death,5,16852164
2,22.1,Haemoptysis,6,16852164
3,22.1,Wound,6,16852164
0,22.1,Abdominal pain,3,16852187
1,22.1,Hepatitis,2,16852187
2,22.1,Pyrexia,3,16852187
3,22.1,Off label use,6,16852187
4,22.1,Pancreatitis,2,16852187
0,22.0,Alopecia,3,16852219
1,22.0,Emotional distress,6,16852219
2,22.0,Anxiety,6,16852219
3,22.0,Impaired quality of life,6,16852219
0,22.0,Alopecia,2,16852227
0,22.0,Alopecia,2,16852235
1,22.0,Psychological trauma,6,16852235
0,22.0,Psychological trauma,6,16852249
1,22.0,Alopecia,2,16852249
0,22.1,Psychological trauma,6,16852260
1,22.1,Alopecia,2,16852260
0,22.1,Psychological trauma,6,16852263
1,22.1,Alopecia,3,16852263
0,22.1,Alopecia,2,16852266
1,22.1,Psychological trauma,6,16852266
0,22.1,Alopecia,2,16852267
0,22.0,Haemorrhage,6,16852298
1,22.0,Contusion,6,16852298
2,22.0,Thrombocytopenia,6,16852298
3,22.0,Impaired healing,3,16852298
0,22.0,Electrocardiogram QT prolonged,3,16852481
0,22.1,Breast cancer,6,16852485
0,22.0,Psychological trauma,6,16852502
1,22.0,Alopecia,2,16852502
0,22.0,Alopecia,2,16852550
1,22.0,Psychological trauma,6,16852550
0,22.0,Hypoacusis,6,16852569
0,22.1,Neutrophilic panniculitis,1,16852659
1,22.1,Febrile neutropenia,1,16852659
2,22.1,Febrile neutropenia,1,16852659
3,22.1,Acute febrile neutrophilic dermatosis,1,16852659
0,22.0,Nausea,6,16852675
1,22.0,Blood creatine phosphokinase increased,6,16852675
2,22.0,Somnolence,6,16852675
0,22.0,Death,5,16852713
0,22.1,Subacute cutaneous lupus erythematosus,1,16852733
0,22.0,Bronchopulmonary aspergillosis,5,16852748
0,22.1,Arthralgia,2,16852750
1,22.1,Myalgia,2,16852750
2,22.1,Polyarthritis,6,16852750
3,22.1,Osteoarthritis,2,16852750
0,22.0,Malignant neoplasm progression,3,16852763
0,22.1,Colorectal cancer metastatic,,16852798
1,22.1,Fatigue,3,16852798
2,22.1,Pain in extremity,3,16852798
3,22.1,Skin lesion,2,16852798
4,22.1,Dysphonia,3,16852798
5,22.1,Nausea,3,16852798
6,22.1,Asthenia,3,16852798
7,22.1,Weight decreased,3,16852798
8,22.1,Diarrhoea,3,16852798
9,22.1,Ocular icterus,3,16852798
10,22.1,Decreased appetite,,16852798
11,22.1,Hypertension,2,16852798
12,22.1,Paraesthesia,3,16852798
13,22.1,Fall,3,16852798
0,22.0,Psychomotor retardation,5,16852935
1,22.0,Pancytopenia,6,16852935
2,22.0,General physical health deterioration,5,16852935
3,22.0,Disorientation,5,16852935
0,22.0,Stomatitis,6,16852943
1,22.0,Product use in unapproved indication,6,16852943
0,22.0,Product use in unapproved indication,6,16852954
1,22.0,Fatigue,6,16852954
0,22.0,Prostatic specific antigen increased,6,16853091
0,22.0,Fatigue,6,16853112
0,22.0,Off label use,6,16853114
1,22.0,Metastases to lymph nodes,5,16853114
2,22.0,Drug resistance,5,16853114
3,22.0,Anaemia,5,16853114
4,22.0,Metastases to liver,5,16853114
5,22.0,Acquired gene mutation,5,16853114
6,22.0,Malignant neoplasm progression,5,16853114
7,22.0,Neutrophil count decreased,6,16853114
8,22.0,Product use in unapproved indication,6,16853114
0,22.0,Pneumonia,6,16853185
0,22.1,Pelvic fluid collection,6,16853188
1,22.1,Blood bilirubin increased,6,16853188
2,22.1,Aspartate aminotransferase increased,6,16853188
3,22.1,Hepatitis,6,16853188
4,22.1,Alanine aminotransferase increased,6,16853188
5,22.1,Hot flush,3,16853188
6,22.1,Nausea,6,16853188
7,22.1,Neutrophil count decreased,6,16853188
8,22.1,Intra-abdominal fluid collection,6,16853188
9,22.1,Malaise,6,16853188
10,22.1,Gamma-glutamyltransferase increased,6,16853188
11,22.1,Anxiety,6,16853188
12,22.1,Decreased appetite,6,16853188
13,22.1,Blood alkaline phosphatase increased,6,16853188
14,22.1,Incontinence,6,16853188
15,22.1,Liver function test abnormal,3,16853188
16,22.1,Metastases to liver,6,16853188
0,22.1,Malignant neoplasm progression,5,16853227
0,22.1,Skin ulcer,6,16853270
1,22.1,Death,5,16853270
0,22.1,Drug-induced liver injury,2,16853283
0,22.1,Hepatocellular injury,6,16853328
1,22.1,Hepatic siderosis,6,16853328
0,22.0,Malignant neoplasm progression,6,16853380
0,22.0,Breast cancer recurrent,6,16853386
1,22.0,Multicentric reticulohistiocytosis,6,16853386
0,22.1,Tachycardia,3,16853455
1,22.1,Ventricular extrasystoles,3,16853455
0,22.1,Drug resistance,6,16853511
0,22.1,Metastases to liver,6,16853529
1,22.1,Nausea,6,16853529
2,22.1,Depressed mood,6,16853529
3,22.1,Toxicity to various agents,6,16853529
4,22.1,Weight decreased,6,16853529
5,22.1,Decreased appetite,6,16853529
6,22.1,Depression,6,16853529
7,22.1,Intentional dose omission,6,16853529
8,22.1,Pain,6,16853529
9,22.1,CYP3A4 polymorphism,6,16853529
10,22.1,Malignant neoplasm progression,6,16853529
11,22.1,Hyperbilirubinaemia,6,16853529
12,22.1,Electrocardiogram QT prolonged,6,16853529
13,22.1,Chest pain,6,16853529
14,22.1,Breast cancer,6,16853529
15,22.1,Pleural disorder,6,16853529
16,22.1,Dyspnoea,6,16853529
0,22.0,Inappropriate schedule of product administration,6,16853677
1,22.0,Death,5,16853677
0,22.1,Enterocolitis infectious,1,16853757
1,22.1,Pneumonia,1,16853757
0,22.1,Neutropenia,2,16853819
1,22.1,Febrile neutropenia,1,16853819
2,22.1,Neutrophilia,1,16853819
0,22.0,Drug hypersensitivity,6,16853830
1,22.0,Therapy partial responder,6,16853830
2,22.0,Ovarian cyst,6,16853830
3,22.0,Pulmonary fibrosis,6,16853830
0,22.0,Interstitial lung disease,6,16853916
1,22.0,Cerebral disorder,6,16853916
2,22.0,Hepatic lesion,6,16853916
3,22.0,Pleural fibrosis,6,16853916
4,22.0,Colon adenoma,6,16853916
5,22.0,Thrombocytopenia,6,16853916
0,22.0,Thrombocytopenia,3,16853920
0,22.1,Thrombocytopenia,1,16853944
1,22.1,Tremor,3,16853944
2,22.1,Autonomic nervous system imbalance,3,16853944
3,22.1,Pelvic pain,2,16853944
0,22.0,Alopecia,2,16853955
1,22.0,Diarrhoea,2,16853955
2,22.0,Paraesthesia,2,16853955
3,22.0,Gastritis,2,16853955
0,22.1,Impaired healing,2,16854056
1,22.1,Tumour perforation,2,16854056
0,22.0,Confusional state,6,16854118
1,22.0,Lethargy,6,16854118
0,22.1,Fatigue,,16854190
1,22.1,Myocardial infarction,,16854190
0,22.1,Enterocolitis,6,16854207
0,22.0,Overdose,3,16854278
0,22.1,Drug ineffective,6,16854326
1,22.1,Anaemia,5,16854326
2,22.1,Drug interaction,5,16854326
3,22.1,Breast cancer,6,16854326
4,22.1,Breast cancer metastatic,5,16854326
5,22.1,Disease progression,5,16854326
6,22.1,Death,5,16854326
7,22.1,Polyneuropathy,5,16854326
8,22.1,Second primary malignancy,2,16854326
9,22.1,Malignant neoplasm progression,6,16854326
10,22.1,Off label use,6,16854326
11,22.1,Thrombocytopenia,5,16854326
12,22.1,Therapy partial responder,6,16854326
13,22.1,Chronic myeloid leukaemia,5,16854326
14,22.1,Product use in unapproved indication,5,16854326
0,22.0,Neoplasm skin,5,16854339
0,22.0,Lymphangioleiomyomatosis,2,16854369
1,22.0,Respiratory failure,2,16854369
0,22.0,Pancytopenia,1,16854384
0,22.1,Hyperhidrosis,1,16854397
1,22.1,Product quality issue,1,16854397
2,22.1,Aggression,1,16854397
3,22.1,Headache,1,16854397
4,22.1,Nausea,1,16854397
5,22.1,Fatigue,1,16854397
6,22.1,Suicidal ideation,1,16854397
0,22.0,Computerised tomogram thorax abnormal,1,16854480
1,22.0,Fatigue,1,16854480
2,22.0,Pyrexia,1,16854480
3,22.0,Atelectasis,1,16854480
4,22.0,Cough,1,16854480
5,22.0,Hypoxia,1,16854480
6,22.0,Rash,1,16854480
7,22.0,Dyspnoea,1,16854480
8,22.0,Gastrointestinal disorder,1,16854480
9,22.0,Nausea,1,16854480
0,22.0,Diarrhoea,2,16854498
1,22.0,Febrile neutropenia,1,16854498
2,22.0,Stomatitis,2,16854498
0,22.1,Hyperammonaemia,1,16854701
0,22.0,Acute myeloid leukaemia,3,16854709
0,22.0,Anaemia,6,16854712
1,22.0,Haematotoxicity,6,16854712
2,22.0,Neutropenia,6,16854712
0,22.1,Pruritus,6,16854725
1,22.1,Intentional product use issue,6,16854725
0,22.1,Radiation pneumonitis,6,16854738
0,22.0,Malignant neoplasm progression,6,16854789
1,22.0,Psoriasis,1,16854789
0,22.1,Deafness,3,16854796
1,22.1,Platelet count decreased,3,16854796
2,22.1,Oesophageal mass,3,16854796
3,22.1,Loss of personal independence in daily activities,6,16854796
4,22.1,Gait disturbance,6,16854796
5,22.1,Anaemia,3,16854796
6,22.1,Nausea,1,16854796
7,22.1,Underdose,6,16854796
8,22.1,Malaise,6,16854796
9,22.1,Balance disorder,6,16854796
10,22.1,Dizziness,3,16854796
11,22.1,Vomiting,1,16854796
12,22.1,Dysstasia,6,16854796
0,22.1,Intestinal obstruction,6,16854805
1,22.1,Heart rate abnormal,6,16854805
2,22.1,Visual impairment,6,16854805
3,22.1,Night sweats,6,16854805
4,22.1,Blood glucose decreased,6,16854805
5,22.1,Anxiety,2,16854805
6,22.1,Palpitations,1,16854805
7,22.1,Heart rate increased,3,16854805
8,22.1,Constipation,3,16854805
9,22.1,Nasal septum deviation,6,16854805
10,22.1,High density lipoprotein increased,6,16854805
11,22.1,Non-high-density lipoprotein cholesterol increased,6,16854805
12,22.1,Dry mouth,6,16854805
13,22.1,Back pain,3,16854805
14,22.1,Dizziness,3,16854805
15,22.1,Thirst,3,16854805
16,22.1,Full blood count decreased,3,16854805
17,22.1,Headache,3,16854805
18,22.1,Product dose omission,6,16854805
19,22.1,Inappropriate schedule of product administration,6,16854805
20,22.1,Abdominal pain upper,6,16854805
21,22.1,Hospitalisation,6,16854805
22,22.1,Blood cholesterol increased,6,16854805
23,22.1,Pain,6,16854805
0,22.1,Intentional product misuse,6,16854818
1,22.1,Platelet count decreased,3,16854818
2,22.1,Haemoglobin decreased,6,16854818
0,22.1,Syncope,6,16854831
1,22.1,Hallucination,6,16854831
2,22.1,Cognitive disorder,3,16854831
3,22.1,Fear of death,6,16854831
4,22.1,Platelet count decreased,3,16854831
5,22.1,Laboratory test abnormal,6,16854831
6,22.1,White blood cell count decreased,6,16854831
7,22.1,Fall,3,16854831
8,22.1,Back pain,6,16854831
9,22.1,Ataxia,3,16854831
10,22.1,Abdominal mass,6,16854831
11,22.1,Asthenia,6,16854831
12,22.1,Haemoglobin decreased,3,16854831
13,22.1,Insomnia,6,16854831
14,22.1,Abdominal lymphadenopathy,6,16854831
15,22.1,Musculoskeletal stiffness,6,16854831
16,22.1,Abdominal pain upper,6,16854831
17,22.1,Carbohydrate antigen 125 increased,3,16854831
18,22.1,Tachycardia,6,16854831
19,22.1,Constipation,6,16854831
20,22.1,Drug ineffective,6,16854831
0,22.0,Cytopenia,3,16854836
0,22.0,Performance status decreased,5,16854853
0,22.0,Deep vein thrombosis,6,16854867
0,22.0,Prostatic specific antigen increased,6,16854868
1,22.0,Metastases to liver,6,16854868
2,22.0,Metastases to bone,6,16854868
0,22.1,Drug resistance,6,16854883
1,22.1,Dizziness,3,16854883
2,22.1,Rash,1,16854883
3,22.1,Malignant neoplasm progression,6,16854883
0,22.0,Acute myeloid leukaemia,2,16854904
1,22.0,Osteonecrosis of jaw,6,16854904
2,22.0,Second primary malignancy,2,16854904
0,22.0,Vogt-Koyanagi-Harada disease,3,16854938
1,22.0,Uveitis,3,16854938
0,22.0,Plantar erythema,1,16854950
1,22.0,Dysaesthesia pharynx,1,16854950
2,22.0,Paraesthesia,1,16854950
3,22.0,Palmar erythema,1,16854950
4,22.0,Erythema,1,16854950
0,22.1,Cholecystitis acute,2,16854969
1,22.1,Procedural haemorrhage,6,16854969
0,22.1,Chronic obstructive pulmonary disease,1,16855006
0,22.0,Bronchospasm,1,16855060
0,22.0,Dyskinesia,6,16855062
0,22.0,Hypertensive crisis,1,16855163
0,22.1,Hospitalisation,,16855240
0,22.1,Erythema,1,16855247
1,22.1,Hypotension,1,16855247
2,22.1,Hepatic function abnormal,2,16855247
3,22.1,Tubulointerstitial nephritis,3,16855247
4,22.1,Pneumonia,6,16855247
5,22.1,Infection,6,16855247
6,22.1,Pyrexia,1,16855247
0,22.0,Pulmonary fibrosis,5,16855270
0,22.0,Lung disorder,6,16855280
0,22.1,Ventricular arrhythmia,,16855333
1,22.1,Pneumonia,,16855333
0,22.1,Disease progression,,16855336
0,22.1,Abdominal pain,,16855341
1,22.1,Influenza,,16855341
2,22.1,Stomatitis,,16855341
0,22.1,Death,,16855355
0,22.1,Disease progression,,16855400
0,22.1,Stomatitis,,16855415
0,22.0,Acute myeloid leukaemia,3,16855422
0,22.1,Dyspnoea,,16855429
1,22.1,Infusion related reaction,,16855429
0,22.0,Death,5,16855461
0,22.0,Muscle injury,6,16855464
1,22.0,Maximal voluntary ventilation abnormal,6,16855464
2,22.0,Dyspnoea,6,16855464
3,22.0,Myopathy toxic,6,16855464
4,22.0,Mitochondrial toxicity,6,16855464
5,22.0,Muscle fatigue,6,16855464
0,22.0,Erysipelas,3,16855484
0,22.1,General physical health deterioration,6,16855586
1,22.1,Intentional product use issue,6,16855586
0,22.1,Speech disorder,,16855587
1,22.1,Movement disorder,,16855587
2,22.1,Gait disturbance,,16855587
0,22.1,Surgery,,16855595
0,22.0,Thrombocytopenic purpura,1,16855659
0,22.1,Pyrexia,1,16855661
1,22.1,Large intestine perforation,1,16855661
0,22.1,Vertigo,6,16855674
1,22.1,Rash maculo-papular,6,16855674
2,22.1,Incorrect route of product administration,6,16855674
0,22.1,Concomitant disease progression,5,16855700
1,22.1,Idiopathic pulmonary fibrosis,5,16855700
2,22.1,Neoplasm progression,5,16855700
0,22.0,Pyrexia,1,16855757
1,22.0,Neutropenia,1,16855757
0,22.1,Renal surgery,,16855767
1,22.1,Therapy cessation,,16855767
0,22.0,Lymphadenopathy,6,16855770
1,22.0,Rash,1,16855770
2,22.0,Rash pruritic,6,16855770
3,22.0,Rash erythematous,1,16855770
4,22.0,Skin exfoliation,6,16855770
5,22.0,Deep vein thrombosis,6,16855770
6,22.0,Arthralgia,2,16855770
7,22.0,Pain,2,16855770
8,22.0,Rash,1,16855770
9,22.0,Skin toxicity,1,16855770
10,22.0,Erythema,6,16855770
11,22.0,Pruritus generalised,1,16855770
12,22.0,Rash,1,16855770
13,22.0,Ligament sprain,1,16855770
14,22.0,Arthralgia,1,16855770
15,22.0,Rash,1,16855770
0,22.1,Hypertensive emergency,,16855782
1,22.1,Thrombotic microangiopathy,,16855782
2,22.1,Anaemia,,16855782
3,22.1,Nausea,,16855782
4,22.1,Therapy cessation,,16855782
5,22.1,Interstitial lung disease,,16855782
6,22.1,Thrombocytopenia,,16855782
7,22.1,Vomiting,,16855782
8,22.1,Acute respiratory failure,,16855782
9,22.1,Acute pulmonary oedema,,16855782
10,22.1,Renal failure,,16855782
0,22.1,Pleural effusion,,16855789
0,22.1,Pain in extremity,,16855798
0,22.0,Acute myeloid leukaemia,3,16855939
0,22.0,Leukopenia,6,16855957
1,22.0,Hypertransaminasaemia,6,16855957
2,22.0,Anaemia,6,16855957
0,22.0,Infection,6,16855961
1,22.0,Cellulitis,6,16855961
0,22.1,Acute pulmonary oedema,3,16855982
1,22.1,Blood creatinine increased,3,16855982
2,22.1,Intestinal obstruction,3,16855982
0,22.0,Gait disturbance,3,16856041
1,22.0,Myalgia,3,16856041
2,22.0,Pain in extremity,3,16856041
3,22.0,Musculoskeletal stiffness,3,16856041
0,22.0,Malignant neoplasm progression,6,16856062
1,22.0,Metastases to lung,6,16856062
2,22.0,Breast cancer,6,16856062
3,22.0,Metastases to liver,6,16856062
0,22.1,Neutropenia,6,16856104
1,22.1,Bronchitis,6,16856104
0,22.1,Decreased immune responsiveness,6,16856131
0,22.1,Hair colour changes,3,16856133
1,22.1,Madarosis,3,16856133
2,22.1,Depression,6,16856133
3,22.1,Hair texture abnormal,3,16856133
4,22.1,Anxiety,6,16856133
5,22.1,Alopecia,3,16856133
6,22.1,Hair disorder,3,16856133
0,22.1,Alopecia,3,16856136
1,22.1,Hair texture abnormal,3,16856136
2,22.1,Madarosis,3,16856136
3,22.1,Hair colour changes,3,16856136
4,22.1,Anxiety,6,16856136
5,22.1,Bipolar disorder,6,16856136
6,22.1,Hair disorder,3,16856136
0,22.0,Blood count abnormal,6,16856142
1,22.0,Fatigue,6,16856142
2,22.0,Glycosylated haemoglobin decreased,6,16856142
0,22.0,White blood cell count abnormal,6,16856149
0,22.0,Migraine,1,16856152
0,22.1,Madarosis,3,16856160
1,22.1,Hair texture abnormal,3,16856160
2,22.1,Hair disorder,3,16856160
3,22.1,Alopecia,3,16856160
4,22.1,Hair colour changes,3,16856160
0,22.1,Hair colour changes,3,16856165
1,22.1,Alopecia,3,16856165
2,22.1,Hair texture abnormal,3,16856165
3,22.1,Madarosis,3,16856165
4,22.1,Hair disorder,3,16856165
0,22.0,Death,5,16856178
0,22.0,Death,5,16856187
0,22.1,Malaise,6,16856205
1,22.1,Inappropriate schedule of product administration,6,16856205
2,22.1,Cytotoxic cardiomyopathy,6,16856205
0,22.0,Neoplasm progression,6,16856220
0,22.1,Confusional state,1,16856221
0,22.0,Fatigue,2,16856242
0,22.1,Eating disorder,3,16856273
0,22.1,Diarrhoea,1,16856284
1,22.1,White blood cell count decreased,3,16856284
2,22.1,Oropharyngeal pain,3,16856284
3,22.1,Neutrophil count decreased,3,16856284
4,22.1,Malignant neoplasm progression,5,16856284
0,22.1,Hair disorder,3,16856290
1,22.1,Hair colour changes,3,16856290
2,22.1,Madarosis,3,16856290
3,22.1,Hair texture abnormal,3,16856290
4,22.1,Alopecia,3,16856290
0,22.0,Fatigue,6,16856297
0,22.1,Vomiting,6,16856341
0,22.1,Hair colour changes,3,16856355
1,22.1,Hair disorder,3,16856355
2,22.1,Alopecia,3,16856355
3,22.1,Hair texture abnormal,3,16856355
4,22.1,Madarosis,3,16856355
0,22.1,Thyroglobulin increased,,16856379
1,22.1,Malignant pleural effusion,3,16856379
2,22.1,Follicular thyroid cancer,5,16856379
3,22.1,General physical health deterioration,3,16856379
0,22.1,Blood pressure increased,1,16856384
1,22.1,Oedema peripheral,1,16856384
2,22.1,Fatigue,1,16856384
3,22.1,Dry skin,1,16856384
4,22.1,Headache,1,16856384
5,22.1,Stomatitis,1,16856384
6,22.1,Abdominal distension,1,16856384
7,22.1,Decreased appetite,1,16856384
8,22.1,Urinary tract infection,3,16856384
9,22.1,Dehydration,1,16856384
10,22.1,Dry mouth,3,16856384
11,22.1,Product use in unapproved indication,3,16856384
12,22.1,Blood pressure diastolic increased,1,16856384
13,22.1,Nausea,1,16856384
14,22.1,Weight decreased,1,16856384
15,22.1,Asthenia,1,16856384
16,22.1,Somnolence,1,16856384
17,22.1,Oral pain,1,16856384
0,22.0,Gastrointestinal necrosis,6,16856406
1,22.0,Ischaemia,6,16856406
2,22.0,Acute abdomen,6,16856406
3,22.0,Abdominal pain,6,16856406
4,22.0,Intestinal ischaemia,5,16856406
0,22.0,Neutropenia,6,16856455
1,22.0,Hyponatraemia,6,16856455
2,22.0,Anaemia,6,16856455
3,22.0,Hypertension,1,16856455
4,22.0,Hypoaesthesia,2,16856455
5,22.0,Decreased appetite,6,16856455
6,22.0,Neuropathy peripheral,2,16856455
0,22.0,Dyspnoea,3,16856483
1,22.0,Decreased appetite,6,16856483
2,22.0,Pneumonia,3,16856483
3,22.0,Cough,3,16856483
4,22.0,General physical health deterioration,3,16856483
5,22.0,Pyrexia,6,16856483
0,22.1,Bone marrow failure,6,16856496
1,22.1,Thrombocytopenia,6,16856496
2,22.1,Neutropenia,6,16856496
3,22.1,Fatigue,6,16856496
0,22.1,Motor dysfunction,2,16856605
1,22.1,Dizziness,2,16856605
2,22.1,Hyperhidrosis,3,16856605
3,22.1,Hot flush,1,16856605
4,22.1,Pain in extremity,3,16856605
5,22.1,Visual impairment,2,16856605
6,22.1,Peripheral swelling,1,16856605
7,22.1,Malignant neoplasm progression,5,16856605
0,22.0,Loss of consciousness,6,16856633
1,22.0,Hair texture abnormal,3,16856633
2,22.0,Cough,6,16856633
3,22.0,Dry mouth,3,16856633
4,22.0,Sjogren^s syndrome,3,16856633
5,22.0,Rash generalised,6,16856633
6,22.0,Bladder cancer,6,16856633
7,22.0,Sleep disorder,6,16856633
8,22.0,Dry skin,3,16856633
9,22.0,Inappropriate schedule of product administration,6,16856633
0,22.0,Pyrexia,6,16856644
0,22.0,Taste disorder,6,16856787
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16856787
2,22.0,Onycholysis,6,16856787
0,22.0,Fatigue,6,16856792
1,22.0,Tinnitus,6,16856792
0,22.1,Metastases to bone,6,16856801
1,22.1,Thyroid mass,6,16856801
0,22.0,Glomerular filtration rate decreased,1,16856810
0,22.0,Nasopharyngitis,3,16857238
1,22.0,Pulmonary oedema,3,16857238
2,22.0,Peripheral swelling,3,16857238
3,22.0,Flushing,3,16857238
4,22.0,Aspartate aminotransferase increased,3,16857238
5,22.0,Lung infection,3,16857238
6,22.0,Metastases to lymph nodes,3,16857238
7,22.0,Blood lactate dehydrogenase increased,3,16857238
8,22.0,Nausea,3,16857238
9,22.0,Metastases to bone,3,16857238
10,22.0,Epistaxis,3,16857238
11,22.0,Blood pressure increased,3,16857238
12,22.0,Ejection fraction,3,16857238
13,22.0,Hepatic enzyme increased,3,16857238
14,22.0,Infusion related reaction,3,16857238
15,22.0,Malignant neoplasm progression,3,16857238
16,22.0,Ill-defined disorder,3,16857238
17,22.0,Blood alkaline phosphatase increased,3,16857238
18,22.0,Hypersensitivity,3,16857238
19,22.0,Rash,3,16857238
20,22.0,Alanine aminotransferase increased,3,16857238
21,22.0,Fatigue,3,16857238
22,22.0,Pulmonary mass,3,16857238
23,22.0,Asthenopia,3,16857238
24,22.0,Gamma-glutamyltransferase increased,3,16857238
0,22.1,Vena cava thrombosis,1,16857331
0,22.0,Death,5,16857369
0,22.0,Death,5,16857377
0,22.0,Death,5,16857389
0,22.0,Proteinuria,1,16857413
1,22.0,Asthenia,1,16857413
2,22.0,Hypercreatinaemia,1,16857413
3,22.0,Gait disturbance,1,16857413
4,22.0,Decreased appetite,1,16857413
5,22.0,Neutrophilia,1,16857413
6,22.0,Dyspnoea,1,16857413
7,22.0,Weight decreased,1,16857413
8,22.0,Leukocytosis,1,16857413
0,22.0,Polydipsia,1,16857421
1,22.0,Flushing,1,16857421
2,22.0,Hyponatraemia,1,16857421
0,22.1,Myofascial pain syndrome,6,16857441
1,22.1,Anxiety,6,16857441
2,22.1,Insomnia,6,16857441
3,22.1,Dyspnoea,6,16857441
4,22.1,Mental disorder,6,16857441
5,22.1,Constipation,6,16857441
6,22.1,Pain,6,16857441
7,22.1,Somatic symptom disorder,6,16857441
0,22.0,Delirium,6,16857444
1,22.0,Vomiting,6,16857444
2,22.0,Asthenia,6,16857444
3,22.0,Constipation,6,16857444
4,22.0,Nausea,6,16857444
5,22.0,Somnolence,6,16857444
0,22.0,Intentional product use issue,6,16857466
1,22.0,Malignant neoplasm progression,6,16857466
2,22.0,Off label use,6,16857466
0,22.0,Death,5,16857469
0,22.0,Spinal cord compression,6,16857475
1,22.0,Liver disorder,6,16857475
0,22.0,Asthenia,1,16857501
1,22.0,Cardiac failure,1,16857501
2,22.0,Confusional state,1,16857501
0,22.0,Surgery,3,16857517
1,22.0,Off label use,,16857517
0,22.0,Death,5,16857521
1,22.0,C-reactive protein increased,6,16857521
2,22.0,Pyrexia,6,16857521
3,22.0,Dyspnoea,6,16857521
4,22.0,Oxygen saturation decreased,6,16857521
0,22.1,Alopecia,2,16857550
1,22.1,Psychological trauma,6,16857550
0,22.0,Drug ineffective,6,16857640
0,22.0,Leukopenia,3,16857668
1,22.0,Rash,3,16857668
2,22.0,Bone marrow failure,6,16857668
3,22.0,Eczema,3,16857668
4,22.0,Nail disorder,3,16857668
5,22.0,Thrombocytopenia,3,16857668
6,22.0,Alopecia,3,16857668
7,22.0,Skin exfoliation,3,16857668
8,22.0,Gastric disorder,3,16857668
9,22.0,Liver disorder,3,16857668
0,22.0,Acute myeloid leukaemia,3,16857684
0,22.1,Neuropathy peripheral,4,16857696
0,22.0,Death,5,16857714
1,22.0,Ammonia increased,3,16857714
2,22.0,Liver disorder,3,16857714
3,22.0,Coma,3,16857714
0,22.1,Pancreatitis,2,16857770
1,22.1,Interstitial lung disease,3,16857770
0,22.0,Alopecia,3,16857832
1,22.0,Hair colour changes,3,16857832
2,22.0,Hair disorder,3,16857832
3,22.0,Depression,6,16857832
4,22.0,Anger,6,16857832
5,22.0,Hair texture abnormal,3,16857832
6,22.0,Madarosis,3,16857832
7,22.0,Anxiety,6,16857832
0,22.1,Alopecia,3,16857835
1,22.1,Hair colour changes,3,16857835
2,22.1,Hair disorder,3,16857835
3,22.1,Hair texture abnormal,3,16857835
0,22.0,Hair disorder,3,16857837
1,22.0,Alopecia,3,16857837
2,22.0,Hair colour changes,3,16857837
3,22.0,Madarosis,3,16857837
4,22.0,Hair texture abnormal,3,16857837
0,22.0,Spinal fracture,6,16857871
1,22.0,Spinal pain,6,16857871
2,22.0,Death,5,16857871
0,22.1,Anaemia,6,16857883
1,22.1,Wrong technique in product usage process,6,16857883
2,22.1,Arterial injury,2,16857883
3,22.1,Arterial injury,1,16857883
0,22.0,Malignant neoplasm progression,6,16857953
0,22.1,General physical health deterioration,1,16857998
0,22.1,Product use in unapproved indication,6,16858036
1,22.1,Iron deficiency anaemia,6,16858036
2,22.1,Fatigue,6,16858036
0,22.1,Intestinal metastasis,6,16858037
1,22.1,Malignant neoplasm progression,6,16858037
2,22.1,Lymphadenopathy,6,16858037
3,22.1,Rectal cancer stage II,6,16858037
4,22.1,Metastases to liver,6,16858037
5,22.1,Colitis,6,16858037
6,22.1,BRAF V600E mutation positive,6,16858037
7,22.1,Pleural effusion,6,16858037
8,22.1,Cholestasis,6,16858037
9,22.1,Pulmonary mass,6,16858037
10,22.1,Rectal cancer,6,16858037
11,22.1,Hepatic cyst,6,16858037
12,22.1,Hydronephrosis,6,16858037
13,22.1,Ileus,6,16858037
0,22.0,Incorrect route of product administration,6,16858050
1,22.0,Thrombocytopenia,6,16858050
2,22.0,Bone marrow failure,6,16858050
3,22.0,Off label use,6,16858050
4,22.0,Nephropathy toxic,6,16858050
5,22.0,Leukopenia,6,16858050
0,22.1,Pulmonary embolism,3,16858064
1,22.1,Weight decreased,3,16858064
2,22.1,Fatigue,6,16858064
3,22.1,Asthenia,6,16858064
4,22.1,Anaemia,1,16858064
5,22.1,Stress,6,16858064
6,22.1,Carbohydrate antigen 125 increased,6,16858064
7,22.1,Decreased appetite,3,16858064
8,22.1,Constipation,6,16858064
9,22.1,Malignant neoplasm progression,6,16858064
10,22.1,Nausea,1,16858064
11,22.1,Tachycardia,6,16858064
12,22.1,Dyspnoea,6,16858064
0,22.0,Blood creatinine increased,6,16858086
1,22.0,Oral mucosal exfoliation,6,16858086
2,22.0,Skin exfoliation,6,16858086
0,22.0,Cerebral infarction,4,16858145
0,22.0,Death,5,16858163
1,22.0,Product use in unapproved indication,6,16858163
0,22.0,Coma,6,16858230
1,22.0,Miosis,6,16858230
0,22.0,Death,5,16858246
1,22.0,Hepatic enzyme increased,6,16858246
0,22.0,Fall,6,16858271
1,22.0,Mobility decreased,6,16858271
0,22.0,Urticaria,6,16858290
1,22.0,Vomiting projectile,6,16858290
2,22.0,Rash,6,16858290
0,22.0,Neutropenia,6,16858293
1,22.0,Oropharyngeal pain,2,16858293
2,22.0,Hepatic mass,6,16858293
3,22.0,Metastases to bone,6,16858293
4,22.0,Functional gastrointestinal disorder,6,16858293
5,22.0,Abdominal distension,6,16858293
6,22.0,Diarrhoea,6,16858293
7,22.0,Pleural effusion,1,16858293
8,22.0,Ascites,6,16858293
9,22.0,Rectal tenesmus,6,16858293
10,22.0,Helicobacter gastritis,6,16858293
11,22.0,Intestinal metastasis,6,16858293
12,22.0,Metastases to peritoneum,6,16858293
13,22.0,Constipation,6,16858293
0,22.1,Drug hypersensitivity,6,16858358
1,22.1,Stevens-Johnson syndrome,1,16858358
2,22.1,Product use in unapproved indication,6,16858358
3,22.1,Inappropriate schedule of product administration,6,16858358
0,22.1,Decreased appetite,6,16858360
1,22.1,Weight decreased,6,16858360
2,22.1,Nausea,6,16858360
3,22.1,Vomiting,6,16858360
4,22.1,Pyrexia,6,16858360
5,22.1,Malignant neoplasm progression,5,16858360
6,22.1,Infection,6,16858360
0,22.1,Pancytopenia,1,16858367
0,22.0,Epistaxis,1,16858408
1,22.0,Fatigue,1,16858408
2,22.0,Rotator cuff syndrome,3,16858408
3,22.0,Thrombophlebitis,1,16858408
4,22.0,Abdominal pain,1,16858408
5,22.0,Facet joint syndrome,3,16858408
6,22.0,Deep vein thrombosis,3,16858408
7,22.0,Back pain,1,16858408
0,22.0,Bone marrow failure,2,16858434
0,22.0,Thrombosis,6,16858436
0,22.0,Abnormal sensation in eye,6,16858483
1,22.0,Retinal detachment,4,16858483
2,22.0,Blindness unilateral,6,16858483
3,22.0,Ocular hyperaemia,6,16858483
0,22.0,Chills,2,16858544
1,22.0,Dyspnoea,2,16858544
2,22.0,Hyperaemia,2,16858544
0,22.1,Delirium,1,16858580
1,22.1,Hallucination,2,16858580
2,22.1,Balance disorder,2,16858580
3,22.1,Depression,2,16858580
4,22.1,Breast cancer recurrent,6,16858580
5,22.1,Speech disorder,2,16858580
6,22.1,Confusional state,2,16858580
7,22.1,Joint stiffness,2,16858580
8,22.1,Gait disturbance,2,16858580
9,22.1,Conjunctivitis,6,16858580
10,22.1,Blood cholesterol increased,2,16858580
11,22.1,Oedema peripheral,2,16858580
12,22.1,Muscle spasms,2,16858580
13,22.1,Hot flush,2,16858580
14,22.1,Myalgia,2,16858580
15,22.1,Malaise,2,16858580
16,22.1,Pain,2,16858580
17,22.1,Polyneuropathy,6,16858580
18,22.1,Neuropathy peripheral,2,16858580
19,22.1,Hypoaesthesia,2,16858580
20,22.1,Insomnia,2,16858580
0,22.0,Weight decreased,3,16858584
1,22.0,Gastrooesophageal reflux disease,6,16858584
2,22.0,Sensation of foreign body,6,16858584
0,22.1,Myocarditis,5,16858765
1,22.1,Rhabdomyolysis,5,16858765
0,22.1,Decreased appetite,6,16858774
1,22.1,Traumatic lung injury,6,16858774
2,22.1,Impaired quality of life,6,16858774
3,22.1,Off label use,6,16858774
4,22.1,Neoplasm progression,6,16858774
5,22.1,Asthenia,6,16858774
6,22.1,Pericardial effusion,3,16858774
7,22.1,Dyspnoea,6,16858774
8,22.1,Gastrointestinal disorder,3,16858774
9,22.1,Weight decreased,3,16858774
0,22.0,Gallbladder rupture,5,16858800
1,22.0,Cholecystitis infective,5,16858800
2,22.0,General physical health deterioration,3,16858800
3,22.0,Cholelithiasis,1,16858800
4,22.0,Septic shock,5,16858800
5,22.0,Cholecystitis,2,16858800
0,22.0,Death,5,16858915
0,22.0,Nausea,6,16858955
1,22.0,Pain,6,16858955
2,22.0,Weight decreased,6,16858955
3,22.0,Weight increased,6,16858955
4,22.0,Haemorrhoids,6,16858955
5,22.0,Lymphoedema,6,16858955
6,22.0,Pyrexia,6,16858955
7,22.0,Tooth disorder,6,16858955
8,22.0,Brain neoplasm,6,16858955
9,22.0,Constipation,6,16858955
10,22.0,Infusion related reaction,6,16858955
11,22.0,Fatigue,6,16858955
12,22.0,Nasopharyngitis,6,16858955
13,22.0,Paranasal sinus discomfort,6,16858955
14,22.0,Urinary tract disorder,6,16858955
15,22.0,Incorrect dose administered,6,16858955
16,22.0,Seizure,6,16858955
17,22.0,Blood pressure decreased,6,16858955
0,22.0,Death,5,16859024
0,22.1,Malaise,6,16859127
1,22.1,Nausea,6,16859127
2,22.1,Decreased appetite,3,16859127
3,22.1,Product use in unapproved indication,3,16859127
4,22.1,Cough,6,16859127
5,22.1,Somnolence,6,16859127
6,22.1,Vomiting,6,16859127
7,22.1,Blood bilirubin increased,6,16859127
8,22.1,Fatigue,1,16859127
0,22.1,Malignant neoplasm progression,6,16859195
1,22.1,Dyspnoea,6,16859195
2,22.1,Pleural effusion,6,16859195
3,22.1,Chest discomfort,6,16859195
4,22.1,Drug resistance,6,16859195
0,22.0,Death,5,16859312
0,22.0,Off label use,6,16859332
1,22.0,Death,5,16859332
0,22.1,Disease progression,5,16859339
1,22.1,Deep vein thrombosis,6,16859339
2,22.1,Hepatic cirrhosis,6,16859339
0,22.1,Weight decreased,6,16859423
0,22.0,Tubulointerstitial nephritis,6,16859431
0,22.1,Confusional state,3,16859460
0,22.0,Therapeutic response decreased,6,16859462
1,22.0,Rash,2,16859462
0,22.1,Renal disorder,6,16859493
1,22.1,Rash,1,16859493
2,22.1,Diarrhoea,1,16859493
0,22.1,Prerenal failure,5,16859655
1,22.1,Vomiting,2,16859655
2,22.1,Sepsis,5,16859655
3,22.1,Diarrhoea,2,16859655
0,22.0,Sepsis,1,16859657
1,22.0,Septic shock,1,16859657
2,22.0,Multiple organ dysfunction syndrome,1,16859657
3,22.0,Pneumonitis,1,16859657
0,22.1,Interstitial lung disease,2,16859686
1,22.1,Stomatitis,1,16859686
2,22.1,Genital ulceration,1,16859686
3,22.1,Neutrophil count decreased,6,16859686
4,22.1,Hiccups,1,16859686
0,22.0,Dementia,2,16859690
0,22.1,Fluid retention,,16859692
0,22.0,Bronchitis viral,2,16859696
1,22.0,Fatigue,2,16859696
0,22.0,Anaemia,3,16859714
0,22.0,Movement disorder,3,16859715
1,22.0,Craniocerebral injury,1,16859715
2,22.0,Gait inability,1,16859715
3,22.0,Muscular weakness,3,16859715
4,22.0,Confusional state,1,16859715
5,22.0,Loss of consciousness,1,16859715
6,22.0,Pain,3,16859715
0,22.1,Cardiac disorder,,16859725
0,22.1,Death,5,16859740
1,22.1,Weight increased,6,16859740
0,22.0,Stress,6,16859745
1,22.0,Hospitalisation,6,16859745
2,22.0,Pain in extremity,6,16859745
3,22.0,Dyspepsia,3,16859745
4,22.0,Arthralgia,6,16859745
5,22.0,Diarrhoea,2,16859745
6,22.0,Fatigue,3,16859745
7,22.0,Somnolence,6,16859745
8,22.0,Back pain,6,16859745
0,22.1,Asthenia,1,16859747
1,22.1,Hypotension,3,16859747
2,22.1,Intentional device misuse,1,16859747
3,22.1,Device issue,6,16859747
4,22.1,Product dose omission,1,16859747
5,22.1,Transient ischaemic attack,1,16859747
6,22.1,Weight decreased,2,16859747
0,22.0,Pulmonary embolism,5,16859864
1,22.0,Somnolence,3,16859864
2,22.0,Confusional state,3,16859864
3,22.0,Drug interaction,5,16859864
0,22.1,Product dose omission,6,16859905
1,22.1,Poisoning,3,16859905
2,22.1,Bladder cancer recurrent,3,16859905
3,22.1,Product availability issue,6,16859905
0,22.1,Psoriasis,2,16859919
1,22.1,Hypothyroidism,3,16859919
2,22.1,Drug hypersensitivity,1,16859919
3,22.1,Colitis,3,16859919
4,22.1,Hyperthyroidism,1,16859919
0,22.1,Liver injury,1,16860005
1,22.1,Gastric perforation,2,16860005
0,22.0,Metastases to liver,6,16860010
1,22.0,Malignant neoplasm progression,6,16860010
2,22.0,Drug resistance,6,16860010
0,22.0,Acquired gene mutation,6,16860011
1,22.0,Malignant neoplasm progression,6,16860011
2,22.0,Malignant transformation,1,16860011
0,22.1,Spinal cord compression,2,16860012
1,22.1,Pathological fracture,2,16860012
2,22.1,Fine motor skill dysfunction,6,16860012
0,22.0,Death,5,16860062
0,22.0,Acute myeloid leukaemia,6,16860081
0,22.0,Death,5,16860085
0,22.0,Neuropathy peripheral,6,16860128
0,22.0,Biliary tract infection,3,16860171
1,22.0,Dehydration,6,16860171
2,22.0,Bacteraemia,6,16860171
0,22.0,Headache,6,16860240
0,22.1,Vision blurred,6,16860244
1,22.1,Influenza like illness,6,16860244
2,22.1,Malaise,6,16860244
3,22.1,Nausea,6,16860244
0,22.0,Nausea,6,16860258
1,22.0,Hunger,6,16860258
2,22.0,Hot flush,6,16860258
3,22.0,Dehydration,6,16860258
4,22.0,Feeling abnormal,6,16860258
0,22.1,Pneumonia,6,16860262
0,22.1,Dysarthria,6,16860277
1,22.1,Anaemia,3,16860277
2,22.1,Visual impairment,6,16860277
3,22.1,Onychomadesis,6,16860277
4,22.1,Dyspnoea,6,16860277
5,22.1,Alopecia,6,16860277
6,22.1,Asthenia,6,16860277
0,22.1,Dyspnoea exertional,6,16860283
1,22.1,Candida infection,6,16860283
2,22.1,White blood cell count decreased,6,16860283
3,22.1,Fatigue,6,16860283
0,22.1,Gastroenteritis viral,1,16860318
1,22.1,White blood cell count decreased,2,16860318
2,22.1,Disease progression,6,16860318
3,22.1,Urinary tract infection,6,16860318
4,22.1,Dehydration,6,16860318
5,22.1,Neutrophil count decreased,6,16860318
0,22.0,Band sensation,2,16860331
1,22.0,Hypotension,2,16860331
0,22.0,Neutropenia,6,16860378
0,22.0,Pseudocirrhosis,6,16860380
1,22.0,Balance disorder,6,16860380
2,22.0,Diarrhoea,6,16860380
3,22.0,Fatigue,6,16860380
4,22.0,Vomiting,6,16860380
5,22.0,Nausea,6,16860380
6,22.0,Weight decreased,6,16860380
7,22.0,Asthenia,6,16860380
8,22.0,Enterocolitis,1,16860380
0,22.0,Palpitations,1,16860406
1,22.0,Decreased appetite,1,16860406
2,22.0,Malignant neoplasm progression,6,16860406
3,22.0,Metastases to central nervous system,6,16860406
4,22.0,Malaise,2,16860406
0,22.0,Radiation pneumonitis,3,16860410
0,22.1,Drug-induced liver injury,6,16860420
1,22.1,Drug-induced liver injury,1,16860420
0,22.1,Ascites,6,16860434
1,22.1,Chills,6,16860434
2,22.1,Jaundice,6,16860434
3,22.1,Malaise,6,16860434
4,22.1,Diarrhoea,6,16860434
0,22.1,Hepatitis,1,16860446
1,22.1,Anaemia,2,16860446
2,22.1,Asthenia,1,16860446
3,22.1,Hypotension,1,16860446
4,22.1,Toxic shock syndrome,6,16860446
5,22.1,Thrombocytopenia,2,16860446
0,22.1,Bronchitis,6,16860454
1,22.1,Pneumonia,6,16860454
0,22.0,Jaundice,3,16860483
1,22.0,Malignant neoplasm progression,6,16860483
2,22.0,Metastases to liver,6,16860483
3,22.0,Tumour marker increased,6,16860483
0,22.1,Memory impairment,6,16860485
0,22.1,Lung disorder,2,16860491
0,22.0,Pancreatitis acute,6,16860493
0,22.1,Anaemia,3,16860501
1,22.1,Diarrhoea,1,16860501
2,22.1,Nausea,2,16860501
3,22.1,Renal impairment,3,16860501
4,22.1,Blood pressure increased,6,16860501
0,22.0,Haemoptysis,3,16860503
0,22.0,Condition aggravated,6,16860548
1,22.0,Disease progression,6,16860548
2,22.0,Therapeutic product effect decreased,6,16860548
0,22.0,Cancer pain,5,16860721
1,22.0,Lung neoplasm malignant,5,16860721
0,22.0,Face oedema,2,16860771
1,22.0,Oral mucosal erythema,2,16860771
2,22.0,Facial pain,2,16860771
0,22.1,Acute hepatic failure,5,16860772
1,22.1,Autoimmune hepatitis,3,16860772
0,22.0,Malignant neoplasm progression,6,16860812
1,22.0,Metastases to central nervous system,6,16860812
2,22.0,Drug resistance,6,16860812
0,22.0,Neoplasm progression,6,16860817
0,22.0,Acute myocardial infarction,5,16860828
1,22.0,Pulmonary congestion,5,16860828
0,22.1,Vomiting,6,16860833
1,22.1,Off label use,6,16860833
2,22.1,Transient ischaemic attack,1,16860833
3,22.1,Left ventricular dysfunction,1,16860833
0,22.0,Thrombocytopenia,3,16860897
0,22.1,Headache,6,16860920
1,22.1,Rash,1,16860920
2,22.1,Pruritus,1,16860920
3,22.1,Nasopharyngitis,3,16860920
4,22.1,Vomiting,6,16860920
5,22.1,Skin exfoliation,1,16860920
6,22.1,Bone pain,6,16860920
7,22.1,Confusional state,6,16860920
8,22.1,Asthenia,6,16860920
9,22.1,Eye disorder,3,16860920
10,22.1,Pain in extremity,3,16860920
11,22.1,Mouth swelling,3,16860920
12,22.1,Alopecia,6,16860920
13,22.1,Pain,6,16860920
14,22.1,Amnesia,3,16860920
15,22.1,Fatigue,3,16860920
0,22.0,Hypokalaemia,1,16860929
0,22.0,Bladder cancer recurrent,2,16860932
1,22.0,Urinary incontinence,6,16860932
2,22.0,Glaucoma,2,16860932
3,22.0,Product availability issue,6,16860932
0,22.1,Myocardial strain,1,16860949
1,22.1,Respiratory failure,1,16860949
2,22.1,Embolism,1,16860949
3,22.1,Pneumonia,6,16860949
0,22.0,Rash,6,16861109
1,22.0,Nausea,6,16861109
2,22.0,Diarrhoea,6,16861109
3,22.0,Stomatitis,6,16861109
0,22.1,Drug-induced liver injury,2,16861132
0,22.0,Pancytopenia,6,16861146
0,22.1,Nausea,,16861178
1,22.1,Diarrhoea,,16861178
2,22.1,Fatigue,,16861178
0,22.1,Immobile,2,16861296
1,22.1,Fall,6,16861296
0,22.0,Diarrhoea,6,16861304
1,22.0,Vomiting,6,16861304
2,22.0,Nausea,6,16861304
0,22.1,Pneumonia legionella,1,16861387
1,22.1,Hot flush,3,16861387
2,22.1,Pulmonary embolism,1,16861387
0,22.1,Hepatic haemorrhage,1,16861390
0,22.1,Hypotension,2,16861408
1,22.1,Dialysis related complication,2,16861408
2,22.1,Death,5,16861408
3,22.1,Hepatic function abnormal,6,16861408
0,22.1,Diabetic metabolic decompensation,2,16861463
1,22.1,Diarrhoea,6,16861463
2,22.1,Metastases to lung,1,16861463
0,22.1,Nausea,1,16861476
1,22.1,Cellulitis,1,16861476
2,22.1,Lethargy,1,16861476
3,22.1,Myalgia,1,16861476
4,22.1,Neutrophil count decreased,1,16861476
0,22.0,Drug resistance,6,16861477
1,22.0,BRAF gene mutation,6,16861477
0,22.0,Hypoaesthesia,3,16861523
0,22.0,Malignant neoplasm progression,6,16861535
1,22.0,Death,5,16861535
0,22.0,Hyperhidrosis,1,16861554
1,22.0,Syncope,1,16861554
2,22.0,Loss of consciousness,1,16861554
3,22.0,Pyrexia,1,16861554
0,22.1,Pneumonia aspiration,1,16861577
1,22.1,Meningitis,3,16861577
0,22.1,Speech disorder,6,16861601
1,22.1,Feeding disorder,6,16861601
2,22.1,Death,5,16861601
3,22.1,Inappropriate schedule of product administration,6,16861601
0,22.1,Malignant neoplasm progression,5,16861617
0,22.1,Atrial fibrillation,2,16861668
0,22.1,Hyperkalaemia,1,16861706
1,22.1,Hyponatraemia,6,16861706
2,22.1,Renal disorder,1,16861706
3,22.1,Off label use,6,16861706
4,22.1,Septic shock,2,16861706
5,22.1,Liver disorder,6,16861706
0,22.0,Intervertebral disc protrusion,6,16861780
1,22.0,Off label use,6,16861780
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16861839
0,22.1,Skin ulcer,,16861846
1,22.1,Pain,,16861846
2,22.1,Visual impairment,,16861846
0,22.1,Hospitalisation,,16861857
1,22.1,Therapy cessation,,16861857
0,22.0,Dehydration,6,16861864
1,22.0,Red blood cell count decreased,6,16861864
2,22.0,White blood cell count decreased,6,16861864
3,22.0,Hypotension,6,16861864
0,22.1,Therapy cessation,,16861873
1,22.1,Cancer surgery,,16861873
0,22.0,Constipation,6,16861874
0,22.1,Radiation pneumonitis,3,16861938
0,22.0,Syncope,6,16861940
0,22.0,Metastases to central nervous system,6,16861947
0,22.0,Hypertransaminasaemia,6,16861998
1,22.0,Anaemia,6,16861998
2,22.0,Leukopenia,6,16861998
0,22.0,Lung disorder,3,16862001
0,22.0,Asthma,6,16862004
1,22.0,Pain in extremity,3,16862004
2,22.0,General physical condition decreased,1,16862004
3,22.0,Alopecia,3,16862004
4,22.0,Neutropenia,1,16862004
5,22.0,Depressed mood,3,16862004
6,22.0,Fatigue,3,16862004
0,22.1,Platelet count decreased,,16862007
0,22.0,Pancytopenia,6,16862014
1,22.0,Acute myeloid leukaemia,6,16862014
0,22.1,Cardiac failure,,16862017
1,22.1,Chest pain,,16862017
2,22.1,Constipation,,16862017
3,22.1,Troponin increased,,16862017
0,22.0,Acute myeloid leukaemia,6,16862025
0,22.1,Constipation,,16862029
0,22.0,Haematemesis,1,16862038
1,22.0,Neoplasm progression,5,16862038
0,22.0,Photosensitivity reaction,3,16862091
1,22.0,Application site erosion,3,16862091
2,22.0,Application site reaction,3,16862091
3,22.0,Scab,3,16862091
4,22.0,Stevens-Johnson syndrome,3,16862091
5,22.0,Skin weeping,3,16862091
0,22.0,Oral mucosal blistering,3,16862137
1,22.0,Pain in extremity,3,16862137
2,22.0,Muscular weakness,3,16862137
3,22.0,Musculoskeletal pain,3,16862137
4,22.0,Neuropathy peripheral,3,16862137
5,22.0,Pain in extremity,3,16862137
6,22.0,Back pain,3,16862137
7,22.0,Abdominal discomfort,3,16862137
8,22.0,Blister,3,16862137
9,22.0,Arthralgia,3,16862137
0,22.1,Laboratory test abnormal,,16862144
0,22.1,Drug ineffective,6,16862180
0,22.0,Arthralgia,,16862183
1,22.0,Musculoskeletal pain,,16862183
2,22.0,Rheumatoid arthritis,,16862183
3,22.0,Alopecia,2,16862183
4,22.0,Pain in extremity,,16862183
0,22.1,Myocardial infarction,1,16862187
0,22.1,Pneumonitis,1,16862193
0,22.0,Pyrexia,6,16862206
1,22.0,Leukopenia,2,16862206
2,22.0,Haemoglobin decreased,3,16862206
3,22.0,Infusion related reaction,6,16862206
4,22.0,Thrombocytopenia,3,16862206
0,22.0,Chest discomfort,6,16862207
1,22.0,Chills,6,16862207
2,22.0,Dyspnoea,6,16862207
0,22.0,Meningitis tuberculous,2,16862214
0,22.1,Drug resistance,6,16862218
1,22.1,Drug hypersensitivity,6,16862218
2,22.1,Malignant neoplasm progression,6,16862218
3,22.1,Drug ineffective,6,16862218
4,22.1,Hydrothorax,6,16862218
0,22.0,Malignant neoplasm progression,6,16862225
1,22.0,Drug resistance,6,16862225
0,22.0,Death,5,16862245
0,22.0,Pulmonary oedema,1,16862285
0,22.0,Neoplasm malignant,6,16862307
0,22.1,General physical health deterioration,6,16862313
1,22.1,Decreased appetite,6,16862313
2,22.1,Breast cancer metastatic,5,16862313
3,22.1,Dyspnoea,1,16862313
0,22.0,Cardiogenic shock,4,16862335
1,22.0,Cardiac failure,4,16862335
2,22.0,Multiple organ dysfunction syndrome,4,16862335
0,22.0,Malignant neoplasm progression,6,16862349
0,22.1,Drug resistance,6,16862351
1,22.1,Malignant neoplasm progression,6,16862351
2,22.1,Fatigue,6,16862351
0,22.0,Madarosis,3,16862357
1,22.0,Hair texture abnormal,3,16862357
2,22.0,Hair colour changes,3,16862357
3,22.0,Hair disorder,3,16862357
4,22.0,Alopecia,3,16862357
0,22.0,Neutropenia,6,16862390
1,22.0,Leukopenia,6,16862390
2,22.0,Bone marrow failure,6,16862390
0,22.0,Drug resistance,6,16862398
1,22.0,Malignant neoplasm progression,6,16862398
2,22.0,Acquired gene mutation,6,16862398
0,22.1,Thrombocytopenia,3,16862402
1,22.1,Hypertransaminasaemia,3,16862402
2,22.1,Paraesthesia,3,16862402
3,22.1,Diarrhoea,3,16862402
4,22.1,Nausea,3,16862402
0,22.1,Incorrect dose administered,6,16862446
1,22.1,Lymphocyte count increased,6,16862446
2,22.1,Abdominal pain,6,16862446
3,22.1,Myalgia,6,16862446
4,22.1,Rash,3,16862446
5,22.1,Fatigue,6,16862446
6,22.1,Muscle injury,6,16862446
7,22.1,Melaena,6,16862446
8,22.1,Hernia,6,16862446
9,22.1,Pain in extremity,6,16862446
0,22.0,Gastritis,1,16862484
1,22.0,Vomiting,6,16862484
2,22.0,Oesophagitis,2,16862484
3,22.0,Fatigue,6,16862484
4,22.0,Myalgia,6,16862484
5,22.0,Pyrexia,6,16862484
6,22.0,Diarrhoea,6,16862484
7,22.0,Nausea,6,16862484
8,22.0,Abdominal pain,6,16862484
0,22.1,Pleural effusion,6,16862508
1,22.1,Acute respiratory distress syndrome,5,16862508
2,22.1,Duodenal ulcer haemorrhage,1,16862508
3,22.1,Pancreatitis acute,5,16862508
4,22.1,Multiple organ dysfunction syndrome,5,16862508
5,22.1,Anaemia,6,16862508
0,22.0,Metastasis,6,16862523
1,22.0,Rash,3,16862523
2,22.0,Drug resistance,6,16862523
3,22.0,Carcinoembryonic antigen increased,6,16862523
0,22.0,Cardiac failure congestive,6,16862525
1,22.0,Pericardial effusion,6,16862525
2,22.0,Pneumonia,6,16862525
3,22.0,Pleural effusion,6,16862525
0,22.0,Thrombocytopenia,6,16862526
0,22.0,Rash,6,16862537
1,22.0,Gastrointestinal motility disorder,6,16862537
0,22.0,Respiratory distress,1,16862554
0,22.1,Hilar lymphadenopathy,6,16862556
1,22.1,Hepatic cyst,6,16862556
2,22.1,Neoplasm progression,6,16862556
3,22.1,Pulmonary mass,6,16862556
4,22.1,BRAF V600E mutation positive,6,16862556
5,22.1,Cholestasis,6,16862556
6,22.1,Pleural effusion,6,16862556
7,22.1,Hydronephrosis,6,16862556
8,22.1,Colitis,6,16862556
9,22.1,Lymphadenopathy mediastinal,6,16862556
10,22.1,Ileus,6,16862556
0,22.0,Prostatic specific antigen increased,3,16862582
1,22.0,Neoplasm progression,3,16862582
0,22.1,Cardiac arrest,5,16862585
1,22.1,Upper gastrointestinal haemorrhage,5,16862585
2,22.1,Lower gastrointestinal haemorrhage,5,16862585
0,22.0,Death,5,16862588
0,22.1,Off label use,6,16862600
1,22.1,Product use in unapproved indication,6,16862600
0,22.0,Off label use,6,16862610
1,22.0,Bronchospasm,1,16862610
2,22.0,Product use in unapproved indication,6,16862610
0,22.0,Total bile acids increased,2,16862625
0,22.0,Drug resistance,6,16862680
1,22.0,Malignant neoplasm progression,6,16862680
2,22.0,Acquired gene mutation,6,16862680
0,22.0,Non-small cell lung cancer,6,16862696
1,22.0,Drug resistance,6,16862696
0,22.1,Lower limb fracture,6,16862713
1,22.1,Nasal disorder,6,16862713
2,22.1,Tonsillar disorder,6,16862713
